← Back to Search
Synthesis And Antimicrobial Activity Of N-alkyl And N-aryl Piperazine Derivatives.
P. Chaudhary, R. Kumar, A. Verma, D. Singh, V. Yadav, A. K. Chhillar, G. Sharma, R. Chandra
Published 2006 · Medicine, Chemistry
Download PDFAnalyze on Scholarcy
A series of substituted piperazine derivatives have been synthesized and tested for antimicrobial activity. The antibacterial activity was tested against Staphylococcus aureus (MTCCB 737), Pseudomonas aeruginosa (MTCCB 741), Streptomyces epidermidis (MTCCB 1824) and Escherichia coli (MTCCB 1652), and antifungal activity against Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger. All synthesized compounds showed significant activity against bacterial strains but were found to be less active against tested fungi. In vitro toxicity tests demonstrated that compounds 4d and 6a showed very less toxicity against human erythrocytes.
This paper references
Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia
M. Sojakova (2004)
Asymmetric hydrogenation of tetrahydropyrazines: Synthesis of (S)-piperazine-2-tert-butylcarboxamide, an intermediate in the preparation of the HIV protease inhibitor indinavir
K. Rossen (1995)
L-735,524: the design of a potent and orally bioavailable HIV protease inhibitor.
B. Dorsey (1994)
Syntheses of optically active tetrahydro-1H-pyrrolo[1,2-a]imidazol-2-ones and hexahydroimidazo[1,2-a]pyridin-2(3H)-ones.
A. Katritzky (2002)
Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections.
S. J. Brickner (1996)
Fluconazole Susceptibility of Vaginal Isolates Obtained from Women with Complicated Candida Vaginitis: Clinical Implications
J. Sobel (2003)
Manual of Clinical Microbiology
J. Jorgensen (2003)
Highly diastereoselective reaction of a chiral, non-racemic amide enolate with (S)-glycidyl tosylate. Synthesis of the orally active HIV-1 protease inhibitor L-735,524
D. Askin (1994)
Interactions of antibiotics of the iturin group with human erythrocytes.
C. Latoud (1986)
Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development.
A. Groll (1998)
A fraction from Escherichia coli with anti-Aspergillus properties.
V. Yadav (2005)
L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.
J. Vacca (1994)
(S)-N-tert-butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide [(S)-WAY-100135]: a selective antagonist at presynaptic and postsynaptic 5-HT1A receptors.
I. Cliffe (1993)
Pharmacokinetic interactions related to the chemical structures of fluoroquinolones.
Y. Mizuki (1996)
Current Clinical Topics in Infectious Diseases
J. Remington (1980)
Synthesis of N-substituted thiazolidines and dihydrobenzothiazoles
A. R. Katritzky (2002)
Properties and Synthetic Utility of N-Substituted Benzotriazoles.
A. Katritzky (1998)
Acid-base behavior of quinolones in aqueous acetonitrile mixtures.
V. Sanz-Nebot (1997)
Quinolone generations: natural history or natural selection?
P. Ball (2000)
Convenient syntheses of unsymmetrical imidazolidines.
A. Katritzky (2002)
Synthesis and structure-activity relationships of a novel series of non-peptide AT2-selective angiotensin II receptor antagonists
M. T. Wu (1993)
Studies on antimycotic properties of Datura metel.
Acid degradation of erythromycin A and erythromycin B
P. Kurath (2005)
2,4-Dihydro-3H-1,2,4-triazole-3-thiones as potential antidepressant agents.
J. Kane (1988)
The chemistry of N-substituted benzotriazoles. Part 14. Novel routes to secondary and tertiary amines and to N, N-disubstituted hydroxylamines
A. R. Katritzky (1989)
Novel diphenylalkyl piperazine derivatives with dual calcium antagonistic and antioxidative activities.
M. Kimura (2002)
Nosocomial acquisition of Candida albicans: an epidemiologic study.
J. Vázquez (1993)
Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents.
J. P. Yevich (1986)
Structural features of piperazinyl-linked ciprofloxacin dimers required for activity against drug-resistant strains of Staphylococcus aureus.
R. Kerns (2003)
Synthesis and in vitro and in vivo antimalarial activity of N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives.
A. Ryckebusch (2003)
Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles, and -1,2,4-triazoles as orally-active, nonulcerogenic antiinflammatory agents.
M. D. Mullican (1993)
Prospective Surveillance of Intravenous Amphotericin B Use Patterns
T. Grasela (1990)
5-Aryl-3-(alkylthio)-4H-1,2,4-triazoles as selective antagonists of strychnine-induced convulsions and potential antispastic agents.
J. M. Kane (1994)
Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 2: asymmetric synthesis and biological evaluation.
H. Zhao (2002)
1,3,4-Oxadiazole, 1,3,4-thiadiazole, and 1,2,4-triazole analogs of the fenamates: in vitro inhibition of cyclooxygenase and 5-lipoxygenase activities.
D. Boschelli (1993)
Optically active antifungal azoles: synthesis and antifungal activity of (2R,3S)-2-(2,4-difluorophenyl)-3-(5-[2-[4-aryl-piperazin-1-yl]-ethyl]-tetrazol-2-yl/1-yl)-1-[1,2,4]-triazol-1-yl-butan-2-ol.
R. S. Upadhayaya (2004)
FORMATION OF PHENYLPIPERAZINES BY A NOVEL ALUMINA SUPPORTED BIS-ALKYLATION
E. Mishani (1996)
Cycloalkylpiperazines as HIV-1 protease inhibitors: enhanced oral absorption
B. Kim (1995)
Amphotericin B-Induced Nephrotoxicity: A Review
V. Fanos (2000)
The fluoroquinolone antibacterials: past, present and future perspectives.
P. Appelbaum (2000)
This paper is referenced by
Synthesis and antimicrobial activity of new 2-piperazin-1-yl-N-1,3-thiazol-2-ylacetamides of cyclopenta[c]pyridines and pyrano[3,4-c]pyridines.
S. Sirakanyan (2020)
Benzotriazole : an excellent ligand for Cu-catalyzed N-arylation of imidazoles with aryl and heteroaryl halides
A. Verma (2007)
Synthesis of New Types of N-Arylpiperazine Phosphoramide Analogues of Chrysin
Xiaolan Chen (2010)
Synthesis, Antibacterial and Antifungal Activities of Novel N,N'-bipyrazole Piperazine Derivatives
Smaail Radi (2012)
2-Furoic piperazide derivatives as promising drug candidates of type 2 diabetes and Alzheimer's diseases: In vitro and in silico studies
M. Abbasi (2018)
Retraction: Novel piperazine core compound induces death in human liver cancer cells: possible pharmacological properties
N. Samie (2016)
Design, synthesis and anti-bacterial studies of piperazine derivatives against drug resistant bacteria.
Saba Tahir (2019)
Structural Conformation of a Novel 1-Benzhydrylpiperazine Derivative: 1-Benzhydryl-4-(toluene-4-sulfonyl)-piperazine
S. Naveen (2009)
Synthesis and antimicrobial screening of 4-thiazolidinone and 2-azetidinone derivatives of piperazine
S. Shingade (2012)
Synthesis and Fungicidal Activities of Novel 1,2,4-Triazole Thione Derivatives Containing 1,2,3-Triazole and Substituted Piperazine Moieties
B. Wang (2016)
C. Kavitha (2013)
Synthesis and Structure-Activity Relationship of 1-(2-Furoyl)Piperazine Bearing Benzamides as Butyrylcholinesterase Inhibitors
Muhammad Athar Abbasi (2020)
Synthesis and Crystal Structure of 1-Benzenesulfonyl-4-benzhydryl-piperazine
C. S. Ananda Kumar (2007)
Piperazine clubbed with 2-azetidinone derivatives suppresses proliferation, migration and induces apoptosis in human cervical cancer HeLa cells through oxidative stress mediated intrinsic mitochondrial pathway
Rashmin Khanam (2018)
Efficient hybrid modeling of CO2 absorption in aqueous solution of piperazine: Applications to energy and environment
Amir Dashti (2019)
Indole Based Weapons to Fight Antibiotic Resistance: A Structure-Activity Relationship Study.
S. Lepri (2016)
Synthesis, characterization, acetylcholinesterase inhibition, and molecular docking studies of new piperazine substituted dihydrofuran compounds
Sait Sari (2020)
Synthesis of 3-[4-(2-furoyl)-1-piperazinyl]-N- (substituted)propanamides as promising antibacterial agents with mild cytotoxicity
Ghulam Hussain (2018)
Efficient synthesis of 1,4-disubstituted polyfunctional piperazines via a sequential one-pot Ugi/nucleophilic addition five-component reaction
Morteza Bararjanian (2010)
FT-IR, FT-Raman and DFT quantum chemical study on the molecular conformation, vibrational and electronic transitions of 1-(m-(trifluoromethyl)phenyl)piperazine.
N. Prabavathi (2014)
Cancer Cell Cytotoxicities of 1-(4-Substitutedbenzoyl)-4-(4-chlorobenzhydryl)piperazine Derivatives
M. Yarim (2012)
Design, Synthesis, and Biological Evaluation of Novel Benzofuran Derivatives Bearing N-Aryl Piperazine Moiety
Yulu Ma (2016)
A highly efficient tandem [3 + 2] “click” cycloaddition/6-exo-cyclization strategy for the construction of triazole fused pyrazines
Biswajit Roy (2014)
Virtual Screening and Biological Evaluation of Piperazine Derivatives as Human Acetylcholinesterase Inhibitors
Kavitha Raj Varadaraju (2013)
C. Kavitha (2014)
Phospha-Michael addition reaction of maleimides employing N-heterocyclic phosphine-thiourea as a phosphonylation reagent: synthesis of 1-aryl-2,5-dioxopyrrolidine-3-yl-phosphonate derivatives.
Nagaraju Molleti (2016)
Electrochemical synthesis based on the oxidation of 1-(4-(4-hydroxyphenyl)piperazin-1-yl)ethanone in the presence of nucleophiles.
A. Amani (2012)
Design, synthesis and bioactivity of novel phthalimide derivatives as acetylcholinesterase inhibitors.
Weijie Si (2016)
SYNTHESIS , CHARACTERIZATION AND ANTIBACTERIAL ACTIVITY OF SOME N-SUBSTITUTED DERIVATIVES OF 6-FLUORO-1-METHYL-4-OXO-7-( PIPERAZIN-1-YL )-4 H-[ 1 , 3 ] THIAZETO [ 3 , 2-A ] QUINOLINE-3-CARBOXYLIC ACID
Debkiron Mukherjee (2014)
Organic metabolites produced by Vibrio parahaemolyticus strain An3 isolated from Goan mullet inhibit bacterial fish pathogens
A. Pandey (2010)
Spectroscopic (FT-IR, FT-Raman), first order hyperpolarizability, NBO analysis, HOMO and LUMO analysis of 1,7,8,9-tetrachloro-10,10-dimethoxy-4-[3-(4-phenylpiperazin-1-yl)propyl]-4-azatricyclo[18.104.22.168(2,6)]dec-8-ene-3,5-dione by density functional methods.
R. Renjith (2014)
C. Kavitha (2013)See more